AstraZeneca today announced that FDA has approved selumetinib for the treatment of pediatric patients, 2 years of age and older, with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN).Read More
The Shah Family Partnering With Children’s National Hospital Establishing The Only Testing Facility Of Its Kind For COVID-19.
Bharti Shah & The Shah Family Meet Their Commitment To Children By Partnering With Children’s National Hospital Establishing The Only Testing Facility Of Its Kind For COVID-19.Read More
CTIS wins $10M Contract to Support Defense Contract Management Agency Application and Database Sustainment Work
CTIS announced that it has been awarded a $10 million contract with the Defense Contract Management Agency (DCMA) to provide sustainment services for DCMA enterprise suite.Read More
Today announced the promotion of Ms. Bharti Shah to Chief Executive Officer. She will have the primary responsibility of overseeing CTIS’ business operations and development for growth opportunities and initiatives. She will continue providing leadership, coordination and day-to-day management for business operations and direct the back-office overseeing the Accounting department, employee well-being along with the HR team.Read More
Yarnoff, is a veteran of the technology marketplace, having held executive positions with numerous solution providers to the federal government. He has held leadership roles in direct sales, sales support, strategic partnership and alliance development, go-to-market strategy formulation, project and portfolio management, corporate branding, training, and related initiatives. Most recently, Bill led the formation and launch of the ACEL360 accelerator for Federal Government contractors. Prior to that, he launched the Meridian International Institute, the revenue-generating arm of the Meridian Global Leadership Institute.Read More
As the Executive Vice President and Chief Medical Officer. She has served for 15 years as the founder and president of Translational Research Group, Inc., a special populations CRO and all-phase research center in Los Angeles conducting studies in internal medicine, endocrinology, infectious disease, chronic pain, gastrointestinal, respiratory, allergy and dermatology.Read More
Rockville, MD – May 21, 2018 – CTIS, Inc., a health informatics company, today announced the promotion of Sudhir Raju to President and Chief Operating Officer. He will have the primary responsibility of overseeing CTIS’s client projects of delivering health informatics solutions including operations, information technology, best practices and account growth. He will also direct the back-office supporting functions including Human Resources and Accounting. In addition, he will serve as the Principal Investigator for the National Cancer Institute’s (NCI’s) Cancer Therapy Evaluation Program’s Enterprise System (CTEP-ESYS) program, developing cancer clinical trials informatics solutions for NCI, National Institutes of Health (NIH).Read More
February 21, 2017 – CTIS is pleased to announce that we have been awarded the Strategic Partners Acquisition Readiness Contract (SPARC) by the Centers for Medicare & Medicaid Services (CMS). This Indefinite Delivery/Indefinite Quantity (IDIQ) base ordering period will span over the next five years with the potential for optional years through 2026.
About the Strategic Partners Acquisition Readiness Contract: SPARC is a multiple award, IDIQ, performance-based contract. A cost-effective, innovative solution, SPARC is available to all components within CMS and all Health and Human Services (HHS) operating divisions to procure information technology (IT) system development services from end to end.
CTIS in Partnership with JHU and BJGMC launches a Mobile Care Van in India to Deliver Health Services
July 25, 2016—CTIS in partnership with The Johns Hopkins Center for Clinical Global Health Education (CCGHE) in Baltimore, Maryland and the Byramjee Jeejeebhoy Government Medical College (BJGMC) in Pune, India launched a custom designed Mobile Health and Wellness Clinic in Pune, India. The mobile clinic will deliver healthcare services and wellness counseling as well as facilitate tuberculosis screening and research funded by Indian government and NIH in the state of Maharashtra in India. Innovative approaches that augment traditional service delivery are needed, such as mobile clinical care, to begin to address healthcare shortcomings. Read the article from Times of India and view the interior description of the van in this video.
Maharashtra is among India’s top regions for cases of both drug-sensitive and multidrug-resistant tuberculosis, and the service area for the clinic comprises a population of 7 million people that includes the city of Pune and surrounding villages. The mobile clinic is equipped with radiology technology, lab equipment, and a patient examination room. The vehicle will also offer tuberculosis screening, diagnostics, and treatment services for patients. “We are highly committed to affecting broad changes in India’s ability to address serious health issues,” said CTIS CEO Raj Shah, “CTIS is pleased to provide a tool that can be used to deliver care where it’s needed most.”
CCGHE Director Dr. Bob Bollinger noted “This effort is about improving the medical care that very sick people receive in an area that has limited healthcare resources. Raj and Bharti Shah are providing a tangible solution to address the problem of access to healthcare, and we hope their incredible generosity will encourage others to support our mission to save and improve the lives of Indian adults and children.”
About the Johns Hopkins Center for Clinical Global Health Education The Johns Hopkins Center for Clinical Global Health Education (CCGHE): is dedicated to improving health outcomes in resource-limited communities by training, supporting, and empowering in-country healthcare providers and health researchers to develop and lead advancements in clinical research, practice, and policy.
June 28, 2016—CTIS is proud to announce that the Health Informatics Solutions (HIS) Group has been appraised at level 3 of the CMMI Institute’s Capability Maturity Model Integration (CMMI)®. The appraisal was performed by SPA Enterprise Services.
CMMI is a capability improvement framework that provides organizations with the essential elements of effective processes that ultimately improve their performance. An appraisal at maturity level 3 indicates the organization is performing at a “defined” level. At this level, processes are well characterized and understood, and are described in standards, procedures, tools, and methods. The organization’s set of standard processes, which is the basis for maturity level 3, is established and improved over time. Refer to the results on the Published Appraisal Results System (PARS).
About CMMI® Institute CMMI Institute (CMMIInstitute.com) is the global leader in the advancement of best practices in people, process, and technology. The Institute provides the tools and support for organizations to benchmark their capabilities and build maturity by comparing their operations to best practices and identifying performance gaps. For over 25 years, thousands of high-performing organizations in a variety of industries, including aerospace, finance, health services, software, defense, transportation, and telecommunications, have earned a CMMI maturity level rating and proved they are capable business partners and suppliers.
CTIS is proud to support and participate at the 2015 Academy of Psychosomatic Medicine (APM) Annual Meeting held in New Orleans, LA from November 11 to November 14, 2015. This conference focuses on “The Art and Science of Communication in Psychosomatic Medicine”. The art of communication revolves around how we interact with our patients, our colleagues, as well as the world at large. The science focuses on our knowledge base, studies and research. The meeting provides a stimulating program which will touch on these varied aspects of communication. Please visit the APM site for more information.Read More
CTIS is awarded the Cancer Therapy Evaluation Program (CTEP) Informatics and Computer Support Task Order
CTIS is pleased to announce that we have been awarded a task order under the CIO-SP3 contract for the Cancer Therapy Evaluation Program (CTEP) Informatics and Computer Support beginning September 15, 2015 by National Cancer Institute (NCI). This task order will span over for the next 7 years. CTIS has been working on the CTEP informatics contract for the last 25 years. The purpose of this task order is to provide development, enhancement, maintenance, and integration support for the CTEP – Enterprise System (CTEP- ESYS) including work that involves other systems that are dependent on or integrated with the CTEP-ESYS.
About Cancer Therapy Evaluation Program (CTEP): The mission of the CTEP is to improve the lives of cancer patients by finding better ways to treat, control and cure cancer. CTEP accomplishes this mission by funding an extensive national program of cancer research and by sponsoring clinical trials to evaluate new anti-cancer agents, with a particular emphasis on translational research to elucidate molecular targets and mechanisms of drug effects.
CTIS exhibited and participated at the 2015 Government-wide Acquisition Contract (GWAC) The American Council for Technology (ACT) - Industry Advisory Council (IAC) Forum that was held in Washington, D.C. This conference discussed how the GWACs are structured to accomplish innovation and best practices around more Government engagement with Industry. The conference also focused on how GWACs brings uncompromising program delivery through quality IT Services during each stage of the acquisition process. Please visit ACT-IAC site for more information.Read More
CTIS was invited by Dr. James Ecklund, Chairman of the Inova Neuroscience Institute to participate with Inova at The Society for Brain Mapping and Therapeutics (SBMT’s) 12th Annual Congress scheduled for March 6-8, 2015 in Los Angeles. Our session discussed “Metadata and Military Medicine” which was chaired by Dr. James Ecklund and Dr. Babak Kateb. During this session, CTIS presented on “The Integration of Social Media in Big Data Collection”. This conference brings together physicians, scientists, policy makers, funding agencies and industry to further the advances and applications in brain and spinal cord mapping and image guided therapies.Read More
On March 3rd, CTIS’ CEO (Raj Shah) and CAO (Bharti Shah) received an award from the Inova Health Foundation, a community-based, not-for-profit healthcare provider. Inova Health Foundation works with individuals, corporations and foundations in the community to assure that everyone has access to healthcare. The award was provided for their generous support to Inova Heart and Vascular Institute (IHVI), Inova Translational Medicine Institute (ITMI) on genomics and Inova Neurosciences and Spine Institute which has made a significant difference in:
On February 20th, CTIS’ CEO, Mr. Raj Shah, and CAO, Ms. Bharti Shah were invited to participate in a roundtable discussion with a small group of 18 people to meet with President Barack Obama. President Obama discussed healthcare, environmental and global economics. The White House has requested a follow-up meeting to discuss health disparities and other issues.Read More
CTIS participates as a Platinum Sponsor at the International Conference on Radiation Biology (ICRB) 2014
CTIS is proud to participate as a Platinum Sponsor at the International Conference on Radiation Biology (ICRB) 2014 that will be hosted by the Institute of Nuclear Medicine and Allied Sciences (INMAS), Delhi, India, from the 11th to the 13th of November. CTIS will support the special session "The Quantitative Imaging Network: Role of Quantitative Imaging in Radiation Therapy" coordinated by Dr. Pushpa Tandon from NIH, USA. The conference encompasses all the major disciplines of radiation sciences and highlights important research areas such as, induction of an effective anti-tumor response by boosting the immune system; prevention, assessment and treatment of radiation injuries; strategies for developing medical countermeasures against ionizing radiations. Please visit ICRB 2014 for more information.Read More